Stone Ridge Asset Management LLC Eli Lilly & CO Transaction History

Stone Ridge Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 06, 2020	SELL	$106.92 - $132.43 $1.4 Million - $1.73 Million	-13,099 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $229,409 - $270,032	-2,061 Reduced 13.59%	13,099 $1.7 Million
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $831,151 - $981,119	-11,200 Reduced 42.49%	15,160 $1.17 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $2.16 Million - $2.32 Million	26,360	26,360 $2.23 Million

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Stone Ridge Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Stone Ridge Asset Management LLC with notifications on news.